Genetic markers for methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis

J Eur Acad Dermatol Venereol. 2022 Jun;36(6):764. doi: 10.1111/jdv.18158.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Case-Control Studies
  • Genetic Markers
  • Humans
  • Methazolamide*
  • Stevens-Johnson Syndrome* / genetics

Substances

  • Genetic Markers
  • Methazolamide